远大医学营养科学（武汉）有限公司

Chinese medical nutrition and pharmaceutical company established on 4 August 2003 in the Jinyinhu ecological park of Dongxihu district, Wuhan, Hubei, on an 80,000 square metre site. Formerly Wuhan Da'an Pharmaceutical and then Grand Life Science (Wuhan), it took its present name in December 2023 and is wholly owned by Grand Life Science (Liaoning) within China Grand Enterprises. Designated a national high-tech enterprise with around 300 staff and 425 million yuan of revenue in 2024, it manufactures medicines, trades medical devices, sells foods for special medical purposes and industrialises a liposomal formulation product line, alongside medical research and development.